Amgen Inc 's ability to collect accounts receivable sequentially worsen to 4.07, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Amgen Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 90 days, from 88 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 431 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2839, from overall ranking in the first quarter 2026 at 2979.

What is Receivable Turnover Ratio?
What is Amgen Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMGN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	17.54 %	12.37 %	41.11 %	16.03 %	25.48 %
Y / Y Revenue Change	9.53 %	5.76 %	8.58 %	12.4 %	9.43 %
Receivable Turnover Ratio (TTM)	4.07	4.15	4.21	4.48	4.52
AMGN's Total Ranking	# 2839	# 2979	# 0	# 0	# 0
Accounts Receivable average collection period days	90	88	87	81	81
Seq. Receivable Change	11.92 %	-4.51 %	12.72 %	-2.43 %	7 %
Seq. Revenue Change	16.66 %	-12.65 %	3.23 %	4.12 %	12.64 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 44
Healthcare Sector	# 432
Overall Market	# 2839

Receivable Turnover Ratio Statistics
High	Average	Low
8.12	6.3	4.07
(Jun 30 2015)		(Jun 30 2026)

AMGN Company Profile • Back to AMGN Efficiency Comparisons • Compare AMGN Receivables Turnover Ratio to its Competitors

Financial Statements
Amgen Inc 's Accounts Receivable	$ 10,227 Millions	Visit AMGN's Balance sheet
Amgen Inc 's Sales TTM	$ 38,095 Millions	Visit AMGN's Income Statement
Sources of AMGN's Revenues		Visit AMGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMGN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMGN's Growth Rates	AMGN's Roa	AMGN's Inventory Turnover Ratio	AMGN's Dividend Comparisons
AMGN's Profitability Ratios	AMGN's Roi	AMGN's Asset Turnover Ratio	AMGN's Dividend Growth
AMGN's Valuation Ratios	AMGN's Roe	AMGN's Financial Strength Ratios	AMGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
The Oncology Institute Inc	9.66	$ 587.244 Millions	$ 60.780 Millions
Sharps Technology Inc	9.65	$ 1.960 Millions	$ 0.203 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Septerna Inc	9.42	$ 98.882 Millions	$ 10.501 Millions
Biofrontera Inc	9.33	$ 45.956 Millions	$ 4.928 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
The Pennant Group Inc	9.27	$ 1,101.710 Millions	$ 118.798 Millions
Crinetics Pharmaceuticals Inc	9.25	$ 42.156 Millions	$ 4.558 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Myomo Inc	9.24	$ 44.242 Millions	$ 4.790 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Bioaffinity Technologies Inc	9.18	$ 5.901 Millions	$ 0.643 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Clene Inc	9.16	$ 0.197 Millions	$ 0.022 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Lexicon Pharmaceuticals Inc	9.14	$ 41.469 Millions	$ 4.535 Millions
Novavax inc	9.06	$ 413.796 Millions	$ 45.668 Millions
Nuvation Bio Inc	9.05	$ 169.551 Millions	$ 18.737 Millions
Cue Biopharma Inc	9.04	$ 37.654 Millions	$ 4.165 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biocryst Pharmaceuticals Inc	9.00	$ 940.613 Millions	$ 104.543 Millions
Edwards Lifesciences Corporation	8.99	$ 6,512.500 Millions	$ 724.750 Millions
Cannapharmarx Inc	8.86	$ 1.699 Millions	$ 0.192 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.